vs

Side-by-side financial comparison of AGENUS INC (AGEN) and La Rosa Holdings Corp. (LRHC). Click either name above to swap in a different company.

AGENUS INC is the larger business by last-quarter revenue ($34.2M vs $20.2M, roughly 1.7× La Rosa Holdings Corp.). La Rosa Holdings Corp. runs the higher net margin — -27.4% vs -31.0%, a 3.7% gap on every dollar of revenue. On growth, AGENUS INC posted the faster year-over-year revenue change (27.5% vs 3.2%). Over the past eight quarters, La Rosa Holdings Corp.'s revenue compounded faster (72.5% CAGR vs 10.5%).

Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.

V. La Rosa and Sons Macaroni Company was founded in 1914 by Vincenzo La Rosa, a Sicilian immigrant. The company eventually became one of the largest regional brands in the United States producing over 40 varieties of pasta.

AGEN vs LRHC — Head-to-Head

Bigger by revenue
AGEN
AGEN
1.7× larger
AGEN
$34.2M
$20.2M
LRHC
Growing faster (revenue YoY)
AGEN
AGEN
+24.3% gap
AGEN
27.5%
3.2%
LRHC
Higher net margin
LRHC
LRHC
3.7% more per $
LRHC
-27.4%
-31.0%
AGEN
Faster 2-yr revenue CAGR
LRHC
LRHC
Annualised
LRHC
72.5%
10.5%
AGEN

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
AGEN
AGEN
LRHC
LRHC
Revenue
$34.2M
$20.2M
Net Profit
$-10.6M
$-5.5M
Gross Margin
8.4%
Operating Margin
42.1%
-24.7%
Net Margin
-31.0%
-27.4%
Revenue YoY
27.5%
3.2%
Net Profit YoY
77.3%
-125.7%
EPS (diluted)
$0.09
$-5.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AGEN
AGEN
LRHC
LRHC
Q4 25
$34.2M
Q3 25
$30.2M
$20.2M
Q2 25
$25.7M
$23.2M
Q1 25
$24.1M
$17.5M
Q4 24
$26.8M
$17.7M
Q3 24
$25.1M
$19.6M
Q2 24
$23.5M
$19.1M
Q1 24
$28.0M
$13.1M
Net Profit
AGEN
AGEN
LRHC
LRHC
Q4 25
$-10.6M
Q3 25
$63.9M
$-5.5M
Q2 25
$-30.0M
$78.4M
Q1 25
$-26.4M
$-95.7M
Q4 24
$-46.8M
$-5.1M
Q3 24
$-67.2M
$-2.5M
Q2 24
$-54.8M
$-2.3M
Q1 24
$-63.5M
$-4.6M
Gross Margin
AGEN
AGEN
LRHC
LRHC
Q4 25
Q3 25
97.9%
8.4%
Q2 25
99.1%
8.0%
Q1 25
99.4%
8.8%
Q4 24
99.6%
8.9%
Q3 24
99.4%
8.3%
Q2 24
99.5%
8.3%
Q1 24
99.6%
8.9%
Operating Margin
AGEN
AGEN
LRHC
LRHC
Q4 25
42.1%
Q3 25
-15.0%
-24.7%
Q2 25
-65.0%
-10.6%
Q1 25
-55.3%
-26.7%
Q4 24
-96.5%
-17.1%
Q3 24
-125.5%
-8.9%
Q2 24
-128.4%
-9.7%
Q1 24
-117.4%
-35.0%
Net Margin
AGEN
AGEN
LRHC
LRHC
Q4 25
-31.0%
Q3 25
211.4%
-27.4%
Q2 25
-116.8%
337.8%
Q1 25
-109.6%
-546.5%
Q4 24
-174.4%
-28.7%
Q3 24
-267.7%
-12.5%
Q2 24
-233.1%
-12.2%
Q1 24
-226.6%
-35.1%
EPS (diluted)
AGEN
AGEN
LRHC
LRHC
Q4 25
$0.09
Q3 25
$1.94
$-5.44
Q2 25
$-1.00
$15.25
Q1 25
$-1.03
$-5.86
Q4 24
$-1.95
$28.54
Q3 24
$-3.08
$-16.49
Q2 24
$-2.52
$-12.49
Q1 24
$-3.04
$-0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AGEN
AGEN
LRHC
LRHC
Cash + ST InvestmentsLiquidity on hand
$3.0M
$4.0M
Total DebtLower is stronger
$44.7M
$642.8K
Stockholders' EquityBook value
$-271.1M
$1.6M
Total Assets
$226.8M
$21.7M
Debt / EquityLower = less leverage
0.41×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AGEN
AGEN
LRHC
LRHC
Q4 25
$3.0M
Q3 25
$3.5M
$4.0M
Q2 25
$9.5M
$5.1M
Q1 25
$18.5M
$2.9M
Q4 24
$40.4M
$1.4M
Q3 24
$44.8M
$1.8M
Q2 24
$93.7M
$1.6M
Q1 24
$52.9M
$1.1M
Total Debt
AGEN
AGEN
LRHC
LRHC
Q4 25
$44.7M
Q3 25
$34.2M
$642.8K
Q2 25
$33.9M
$644.3K
Q1 25
$33.6M
$645.9K
Q4 24
$33.2M
$647.6K
Q3 24
$649.2K
Q2 24
$650.8K
Q1 24
$652.4K
Stockholders' Equity
AGEN
AGEN
LRHC
LRHC
Q4 25
$-271.1M
Q3 25
$-274.1M
$1.6M
Q2 25
$-354.6M
$3.4M
Q1 25
$-341.8M
$-87.5M
Q4 24
$-326.4M
$2.6M
Q3 24
$-292.3M
$5.0M
Q2 24
$-241.3M
$4.7M
Q1 24
$-201.4M
$5.6M
Total Assets
AGEN
AGEN
LRHC
LRHC
Q4 25
$226.8M
Q3 25
$233.9M
$21.7M
Q2 25
$185.2M
$22.9M
Q1 25
$200.2M
$21.0M
Q4 24
$226.3M
$19.4M
Q3 24
$238.5M
$19.7M
Q2 24
$292.4M
$18.7M
Q1 24
$256.6M
$16.3M
Debt / Equity
AGEN
AGEN
LRHC
LRHC
Q4 25
Q3 25
0.41×
Q2 25
0.19×
Q1 25
Q4 24
0.25×
Q3 24
0.13×
Q2 24
0.14×
Q1 24
0.12×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AGEN
AGEN
LRHC
LRHC
Operating Cash FlowLast quarter
$-16.6M
$-1.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AGEN
AGEN
LRHC
LRHC
Q4 25
$-16.6M
Q3 25
$-14.7M
$-1.3M
Q2 25
$-20.2M
$-1.4M
Q1 25
$-25.6M
$-3.5M
Q4 24
$-28.7M
$-1.1M
Q3 24
$-53.3M
$-591.6K
Q2 24
$-38.2M
$-803.1K
Q1 24
$-38.2M
$-538.3K
Free Cash Flow
AGEN
AGEN
LRHC
LRHC
Q4 25
Q3 25
Q2 25
$-20.2M
Q1 25
$-25.6M
Q4 24
$-28.7M
Q3 24
$-53.3M
Q2 24
$-38.6M
Q1 24
$-38.2M
FCF Margin
AGEN
AGEN
LRHC
LRHC
Q4 25
Q3 25
Q2 25
-78.7%
Q1 25
-106.5%
Q4 24
-107.0%
Q3 24
-212.2%
Q2 24
-164.4%
Q1 24
-136.5%
Capex Intensity
AGEN
AGEN
LRHC
LRHC
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
0.3%
Q3 24
0.0%
Q2 24
2.0%
Q1 24
0.1%
Cash Conversion
AGEN
AGEN
LRHC
LRHC
Q4 25
Q3 25
-0.23×
Q2 25
-0.02×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AGEN
AGEN

Non Cash Royalty Revenue$31.1M91%
Other$3.2M9%

LRHC
LRHC

Real Estate Residential Brokerage Services$16.8M83%
Transferred Over Time$3.5M17%

Related Comparisons